rs3132581
MUCL3;SFTA2;HCG21
Attention deficit hyperactivity disorder
G
0.800
GeneticVariation
GWASDB
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Attention deficit hyperactivity disorder
G
0.800
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs115123027
MUCL3;SFTA2
Schizophrenia
T
0.700
GeneticVariation
GWASCAT
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
30285260
2019
rs114115252
×
Entrez Id:
389376
Gene Symbol:
SFTA2
SFTA2
Schizophrenia
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
rs114115252
×
Entrez Id:
389376
Gene Symbol:
SFTA2
SFTA2
Child Development Disorders, Pervasive
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
rs114838832
MUCL3;SFTA2
Schizophrenia
A
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
rs114838832
MUCL3;SFTA2
Child Development Disorders, Pervasive
A
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
rs3132580
MUCL3;SFTA2;HCG21
Lupus Erythematosus, Systemic
A
0.700
GeneticVariation
GWASDB
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.
24871463
2014
rs2253705
×
Entrez Id:
389376
Gene Symbol:
SFTA2
SFTA2
Hepatitis B
0.700
GeneticVariation
GWASDB
A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.
23760081
2013
rs3132581
MUCL3;SFTA2;HCG21
Child Development Disorders, Pervasive
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Bipolar Disorder
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Major Depressive Disorder
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Schizophrenia
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132580
MUCL3;SFTA2;HCG21
Malignant neoplasm of lung
0.700
GeneticVariation
GWASDB
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.
22899653
2012
rs3132580
MUCL3;SFTA2;HCG21
Myasthenia Gravis
0.700
GeneticVariation
GWASDB
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
23055271
2012
rs6933400
MUCL3;SFTA2
Coronary heart disease
0.700
GeneticVariation
GWASDB
Genome-wide association study of coronary artery disease in the Japanese.
21971053
2012
rs3132580
MUCL3;SFTA2;HCG21
Membranous glomerulonephritis
T
0.700
GeneticVariation
GWASCAT
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.
21323541
2011
rs12190030
MUCL3;SFTA2;HCG21
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs12190030
MUCL3;SFTA2;HCG21
HIV-1, RESISTANCE TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs12190030
MUCL3;SFTA2;HCG21
AIDS, PROGRESSION TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs12190030
MUCL3;SFTA2;HCG21
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs3132580
MUCL3;SFTA2;HCG21
Vitiligo
0.700
GeneticVariation
GWASDB
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
20526339
2010
rs12697941
MUCL3;SFTA2
AIDS, PROGRESSION TO
0.700
GeneticVariation
GWASDB
Common genetic variation and the control of HIV-1 in humans.
20041166
2009
rs12697941
MUCL3;SFTA2
HIV-1, RESISTANCE TO
0.700
GeneticVariation
GWASDB
Common genetic variation and the control of HIV-1 in humans.
20041166
2009
rs12697941
MUCL3;SFTA2
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.700
GeneticVariation
GWASDB
Common genetic variation and the control of HIV-1 in humans.
20041166
2009